These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients. van Gelder T; Knoop CJ; Hesse CJ; Vaessen LM; Balk AH; Yzermans JN; Weimar W Transplant Proc; 1995 Feb; 27(1):856-8. PubMed ID: 7879206 [No Abstract] [Full Text] [Related]
26. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies. Frank R; Dean SA; Molina MR; Kamoun M; Lal P Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957 [TBL] [Abstract][Full Text] [Related]
28. Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients. Pérez-Flores I; Sánchez-Fructuoso A; Santiago JL; Fernández-Arquero M; Calvo N; de la Concha EG; Barrientos A Transplant Proc; 2009; 41(6):2106-8. PubMed ID: 19715845 [TBL] [Abstract][Full Text] [Related]
29. Lymphocyte status in endomyocardial biopsies and blood after heart transplantation. Schuurman HJ; Gmelig Meyling FH; Wijngaard PL; Van der Meulen A; Slootweg PJ; Jambroes G J Pathol; 1989 Nov; 159(3):197-203. PubMed ID: 2574232 [TBL] [Abstract][Full Text] [Related]
30. The development of transplant coronary artery disease after cardiac transplantation is correlated with a predominance of CD8+ T lymphocytes in endomyocardial biopsy derived T cell cultures. Jutte NH; Groeneveld K; Balk AH; Ouwehand AJ; Loonen EH; Van der Linden M; Strikwerda S; Mochtar B; Claas FH; Weimar W Clin Exp Immunol; 1994 Oct; 98(1):158-62. PubMed ID: 7923876 [TBL] [Abstract][Full Text] [Related]
31. Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients. Lagoo AS; George JF; Naftel DC; Griffin AK; Kirklin JK; Lagoo-Deenadayalan S; Hardy KJ; Savunen T; McGiffin DC J Heart Lung Transplant; 1996 Feb; 15(2):206-17. PubMed ID: 8672525 [TBL] [Abstract][Full Text] [Related]
33. The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance. Nomura M; Plain KM; Verma N; Robinson C; Boyd R; Hodgkinson SJ; Hall BM Transpl Immunol; 2006 Apr; 15(4):311-8. PubMed ID: 16635754 [TBL] [Abstract][Full Text] [Related]
34. Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery. Tian L; Lu L; Yuan Z; Lamb JR; Tam PK Transplantation; 2004 Jan; 77(2):183-9. PubMed ID: 14742978 [TBL] [Abstract][Full Text] [Related]
35. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients. Calmus Y; Scheele JR; Gonzalez-Pinto I; Jaurrieta EJ; Klar E; Pageaux GP; Scudamore CH; Cuervas-Mons V; Metselaar HJ; Prestele H; Girault D Liver Transpl; 2002 Feb; 8(2):123-31. PubMed ID: 11862588 [TBL] [Abstract][Full Text] [Related]